Pancrelipase (marketed as Creon) Information

FDA has approved pancrelipase (Creon Delayed-Release Capsules) for adult and pediatric patients with exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF), chronic pancreatitis, and other conditions.

• Approval letter
• FDA Response to Citizen Petition
• Questions and Answers

PDF requires the free Adobe Acrobat Reader

Date created: May 1, 2009

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research